We are pleased to announce that, as part of action 2.4 Research Infrastructure for a Modern Economy (FENG), the research team consisting of:
has secured funding for the POL-OPENSCREEN – Polish Platform of Screening Infrastructure for Biological Chemistry.
POL-OPENSCREEN is a direct continuation of the POL-OPENSCREEN project implemented between 2021 and 2023, which aims to develop the POL-OPENSCREEN infrastructure. The project is the result of collaboration with the Institute of Medical Biology Polish Academy of Sciences (consortium leader) and the Centre of Molecular and Macromolecular Studies Polish Academy of Sciences. The following IBCH PAS units are involved in the project: Centre for Chemical Biology ERIC, including the Laboratory of Medicinal Chemistry (headed by Dorota Jakubczyk, PhD) and the Laboratory of Molecular Assays and Imaging (headed by Dorota Kwiatek, PhD), and the Department of Structural Biology of Eukaryotes (headed by Miłosz Ruszkowski, PhD, DSc, Assoc. Prof.).
The aim of the project is to develop a unique in Poland and world-leading comprehensive infrastructure for molecular target identification, screening, verification and optimisation of biologically active substances. The planned universal design of the platform will allow the discovery and development of substances with potential medical applications, in particular drugs, but also chemical compounds and other substances for use in basic research as, for example, selective inhibitors and in the agricultural, food or cosmetic industries, in a high-throughput and efficient manner.
The total funding for the project amounts to PLN 24,831,715.68 (of which the funding for IBCH PAS is PLN 15,649,507.20). The project will be implemented between 2025 and 2027.
Accessibility Tools
